MiniMed Group, Inc. Common Stock (MMED) is a publicly traded the market company. As of September 24, 2026, MMED trades at $20.54 with a market cap of $5.96B and a P/E ratio of -15.73. MMED moved -3.21% today. Year to date, MMED is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $10.65 to $24.43. Analyst consensus is strong buy with an average price target of $26.11. Rallies surfaces MMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks MMED insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $20.54 |
| Market Cap | $5.96B |
| P/E Ratio | -15.73 |
| EPS | $-1.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.43 |
| 52-Week Low | $10.65 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.10B |
| Net Income | $-317.00M |
| Gross Margin | 54.16% |
10 analysts cover MMED: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.11.